Publicaciones en las que colabora con JUAN DE DIOS LUNA DEL CASTILLO (47)

2020

  1. Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection

    Medicina Clinica, Vol. 155, Núm. 4, pp. 159-161

2019

  1. Linking of psoriasis with osteopenia and osteoporosis: A cross-sectional study

    Indian Journal of Dermatology, Venereology and Leprology, Vol. 85, Núm. 2, pp. 153-159

  2. Potential drug–drug interactions in deceased inpatients

    Internal and Emergency Medicine

  3. Prevalence and risk factors associated with fatal adverse drug reactions among patients admitted at a Spanish teaching hospital

    European Journal of Internal Medicine

2018

  1. Circulating levels of sclerostin are associated with cardiovascular mortality

    PLoS ONE, Vol. 13, Núm. 6

  2. Clinical predictors of candidemia in medical non-neutropenic, non-ICU patients. The CaMed score

    International Journal of Clinical Practice, Vol. 72, Núm. 12

  3. Effect of ethnicity on clinical presentation and risk of antiphospholipid syndrome in Roma and Caucasian patients with systemic lupus erythematosus: a multicenter cross-sectional study

    International Journal of Rheumatic Diseases, Vol. 21, Núm. 11, pp. 2028-2035

  4. Mortalidad hospitalaria asociada a medicamentos en un Servicio de Medicina Interna

    Anales del sistema sanitario de Navarra, Vol. 41, Núm. 3, pp. 339-346

  5. Potentially inappropriate prescribing according to STOPP-2 criteria among patients discharged from Internal Medicine: prevalence, involved drugs and economic cost

    Archives of Gerontology and Geriatrics, Vol. 74, pp. 150-154

2016

  1. Drug-related mortality among inpatients: a retrospective observational study

    European Journal of Clinical Pharmacology, Vol. 72, Núm. 6, pp. 731-736

2015

  1. Umbilical cord serum lipids between early and late clamping in full-term newborns. A systematic assignment treatment group

    Journal of Maternal-Fetal and Neonatal Medicine, Vol. 28, Núm. 2, pp. 186-189

2014

  1. Analysis of measurement process of placental volume in early pregnancy: An interobserver reliability study

    Journal of Perinatal Medicine, Vol. 42, Núm. 5, pp. 559-564

2012

  1. Impact of a 'school-based' nutrition intervention on anthropometric parameters and the metabolic syndrome in Spanish adolescents

    Annals of Nutrition and Metabolism, Vol. 61, Núm. 4, pp. 281-288

  2. Long-term consequences of uninephrectomy in male and female rats

    Hypertension, Vol. 60, Núm. 6, pp. 1458-1463

2010

  1. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor κb in women with postmenopausal osteoporosis

    Menopause, Vol. 17, Núm. 1, pp. 140-144

2009

  1. Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools

    Journal of Medical Virology, Vol. 81, Núm. 5, pp. 763-767

2008

  1. Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in post-menopausal osteoporosis

    Journal of Endocrinological Investigation, Vol. 31, Núm. 5, pp. 416-421

  2. Effects of risedronate on metabolic bone disease in patients with type 1 diabetes and osteoporosis

    Revista Española de Enfermedades Metabólicas Oseas, Vol. 17, Núm. 4, pp. 66-70

2007

  1. Successful Kidney Transplantation Reduces Hyperplastic Parathyroid Gland

    Transplantation Proceedings, Vol. 39, Núm. 1, pp. 125-131

2005

  1. The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women

    Osteoporosis International, Vol. 16, Núm. 11, pp. 1368-1374